Do the dissociative side effects of ketamine mediate its antidepressant effects?

Luckenbaugh, David A., Niciu, Mark J., Ionescu, Dawn F., Nolan, Neal M., Richards, Erica M., Brutsche, Nancy E., Guevara, Sara, Zarate, Carlos A.·2014·Journal of Affective Disorders
DOI 10.1016/j.jad.2014.02.017

Cited by (284)

Items 201–284 of 284

  1. Striking Similarities between Clinical and Biological Properties of Ketamine and Ethanol: Linking Antidepressant-After Effect and Burgeoning Addiction?
    Udo Bonnet Norbert Scherbaum · 2014 · Journal of Alcoholism and Drug Dependence
  2. Delayed increase of thrombocyte levels after a single sub-anesthetic dose of ketamine – A randomized trial
    Lejla Čolić, Marie Woelfer, Merima Čolić, Anna Linda Leutritz, Thomas Liebe, Luisa Fensky, Zümrüt Duygu Şen, Meng Li, Juliane Hoffmann, Moritz Kretzschmar et al. · 2018 · European Neuropsychopharmacology
  3. KETAMINE AS A POSSIBLE MODERATOR OF HYPNOTIZABILITY: A Feasibility Study
    David R. Patterson, Christine J. Hoffer, Mark P. Jensen, SHELLEY A. WIECHMAN, Sam R. Sharar · 2018 · International Journal of Clinical and Experimental Hypnosis
  4. OAV and 5D-ASC for Brazilian Portuguese: A validation and adaptation study
    Rafael Rodrigues, Isabel Wießner, Dimitri Daldegan‐Bueno, Bheatrix Bienemann, Alexandre Augusto de Deus Pontual, Luís Fernando Tófoli, Daniel C. Mograbi · 2025 · Journal of Psychopharmacology
  5. Switching to Intranasal Esketamine Maintains the Antidepressant Response to Intravenous Racemic Ketamine Administration
    Michael D. Banov, Rachel E. Landrum, Michelle B. Moore, Steven T. Szabo · 2021 · Journal of Clinical Psychopharmacology
  6. Targeting Affective Mood Disorders With Ketamine to Prevent Chronic Postsurgical Pain
    Dianna E. Willis, Peter A. Goldstein · 2022 · Frontiers in Pain Research
  7. Ketamine and Depression: A Review
    Wesley C. Ryan, Cole J. Marta, Ralph J. Koek · 2014 · International Journal of Transpersonal Studies
  8. The influence of subanaesthetic ketamine on regional cerebral blood flow in healthy dogs measured with 99mTc-HMPAO SPECT
    Lise Vlerick, Kathelijne Y. Peremans, Robrecht Dockx, Kurt Audenaert, Chris Baeken, Bart M. J. De Spiegeleer, Jimmy H. Saunders, Ingeborgh Polis · 2018 · PLoS ONE
  9. Ketamine: Clinical Studies in Treatment-Resistant Depressive Disorders
    Pierre Blier, Jean Blier · 2016 · Springer eBooks
  10. The Role of Psychedelics in the Treatment of Substance Use Disorders: An Overview of Systematic Reviews
    Sabrina Corrêa da Costa, Nicholas L. Bormann, Tyler Oesterle, Michele T. McGinnis, Ming‐Fen Ho, Sara A. Vettleson-Trutza, Teresa A. Rummans, Mark S. Gold · 2025 · Brain Sciences
  11. A Meta-Analysis of Functional Neuroimaging Studies of Ketamine Administration in Healthy Volunteers
    Karim Ait Bentaleb, Mélanie Boisvert, Valérie Tourjman, Stéphane Potvin · 2023 · Journal of Psychoactive Drugs
  12. Rapid and sustained reduction of treatment-resistant PTSD symptoms after intravenous ketamine in a real-world, psychedelic paradigm
    Henry A. MacConnel, Mitch Earleywine, Steven Radowitz · 2024 · Journal of Psychopharmacology
  13. A comparison of the safety, feasibility, and tolerability of ECT and ketamine for treatment-resistant depression
    Amanda J. F. Tamman, Amit Anand, Sanjay J. Mathew · 2022 · Expert Opinion on Drug Safety
  14. Hot and cold cognition in major depressive disorder
    Oliver Joe Robinson, Jonathan Paul Roiser, Barbara Jacquelyn Sahakian · 2015 · Cambridge University Press eBooks
  15. Intravenous ketamine infusion for a patient with treatment-resistant major depression: a 10-month follow-up
    Ji‐Hye Kwon, Woo-Seok Sim, J. P. Hong, I. S. Song, J. Y. Lee · 2018 · Journal of Clinical Pharmacy and Therapeutics
  16. Party drug’s power to fight depression puzzles scientists
    Sara Reardon · 2017 · Nature
  17. Authors' reply
    Reinders, Antje A. T. S., Young, Allan H., Veltman, Dick J. · 2022 · The British Journal of Psychiatry
  18. Combining DNA methylation features and clinical characteristics predicts ketamine treatment response for PTSD
    Amir Valizadeh, John D. Roache, Xinyu Zhang, Ying Hu, Ralitza Gueorguieva, Lynnette A. Averill, Mohini Ranganathan, Zuoheng Wang, Douglas E. Williamson, Paulo R. Shiroma et al. · 2025 · iScience
  19. Long-Term Effects of Single and Repeated Ketamine Infusions on Treatment-Resistant Depression: A Retrospective Chart Review Study
    Sofia Sakopoulos, Lisa D. Hinz · 2024 · Psychoactives
  20. Several reasons why ketamine as a neuroplastic agent may have failed to prevent postoperative delirium: Implications for future protocols
    Jiřı́ Horáček, Robert Janda, Natálie Görnerová, Lucia Jajcay, Veronika Andrashko · 2023 · Neuroscience Letters
  21. Glutamate Pharmacological Models Relevant to Schizophrenia and Psychosis
    M. D. Rafter, Kevin C.F. Fone, Paula M. Moran · 2015 · Handbook of behavioral neuroscience
  22. Ketamine’s Mechanism of Rapid Antidepressant Activity: Evidence Gleaned from Clinical Studies
    Lynnette A. Averill, James W. Murrough, Chadi G. Abdallah · 2016 · Springer eBooks
  23. Acute Subjective Experiences of Intravenous Ketamine Therapy Among Medically Hospitalized Patients with Alcohol Use Disorder
    Dale Terasaki · 2024 · Psychedelic Medicine
  24. Ketamine's Altered States Meta-Analysis
    Vagner Deuel de Oliveira Tavares, Kaike Thiê da Costa Gonçalves, Maria Luiza de Morais Barros, Aldielyson Jorge Cavalcante de Brito, Patrícia Cavalcanti-Ribeiro, Fernanda Palhano-Fontes, Marcelo Falchi-Carvalho, Emerson Arcoverde Nunes, Jerome J. Sarris, Daniel Perkins et al. · 2024 · Journal of Clinical Psychopharmacology
  25. High Baseline Plasma Anthranilic Acid Predicts Remission Upon Acute-Series Ketamine Infusion for Treatment-Resistant Depression
    Stephen Murata, Zachary Madaj, Colt D. Capan, Ryan D. Sheldon, Rif S. El‐Mallakh, Sagar V. Parikh, William Victor Bobo, Fernando S. Goes, Owen M. Wolkowitz, Jennifer L. Vande Voort et al. · 2025 · Biological Psychiatry Global Open Science
  26. Understanding the Experience of Ketamine-Assisted Therapy and the Importance of Context
    Grace Stockwell, Nicholas R. Hoeh, Francesca A. Fogarty, Cerys Clayden, Lisa Reynolds · 2025 · Journal of Psychoactive Drugs
  27. Ketamine: An Update for Its Use in Complex Regional Pain Syndrome and Major Depressive Disorder
    William E. Bentley · 2015 · Clinical and Experimental Pharmacology
  28. Psychedelic Psychiatry
    David A. Bender, Joshua S. Siegel · 2024 · Elsevier eBooks
  29. General Anesthesia Occludes Ketamine's Antidepressant Response in a Rodent Model of Chronic Stress
    Daniel Markman, Andrzej Z. Wasilczuk, Joseph Cichon · 2024 · Psychedelic Medicine
  30. Negative emotionality shapes the modulatory effects of ketamine and lamotrigine in subregions of the anterior cingulate cortex
    Matti Gärtner, Anne Weigand, Marvin Sören Meiering, David Weigner, Luisa Carstens, Christian Keicher, Rita Hertrampf, Christian F. Beckmann, Maarten Mennes, Andreas Wunder et al. · 2024 · Translational Psychiatry
  31. Oral Ketamine as a Treatment Option in Patients With Treatment Resistant Depression and Comorbid Arterial Hypertension
    L. Silberbauer, Lucie Bartova, Konstantinos Papageorgiou, Rupert R. Lanzenberger, Siegfried F. Kasper, Dietmar Winkler · 2020 · Journal of Clinical Psychopharmacology
  32. Cortical thickness of the posterior cingulate cortex is associated with the ketamine-induced altered sense of self: An ultra-high field MRI study
    Lena Vera Danyeli, Zümrüt Duygu Şen, Lejla Čolić, Nils Opel, Alexander Refisch, Nikolai Blekic, Tamar Macharadze, Moritz Kretzschmar, Matthias H. J. Munk, Christian Gaser B et al. · 2024 · Journal of Psychiatric Research
  33. A placebo-controlled crossover study of iloperidone augmentation for residual anger and irritability in major depressive disorder
    Dawn Flosnik Ionescu, Maurizio Fava M. D, Daniel Ju Hyung Kim, Lee Baer, Richard Charles Shelton, Cristina Cusin · 2015 · Therapeutic Advances in Psychopharmacology
  34. Oral Prolonged-Release Ketamine for Treatment-Resistant Depression
    Martin Walter, Christine zu Eulenburg, A. Damyanova, Karin Schmid, Isabel Schwienbacher, Evangelos Papanastasiou, K. Maiboe, Lars Arvastson, Caren Strote, Daniel Gehrlach et al. · 2026 · JAMA Network Open
  35. Ketamine for Depression: A Mixed-Methods Study
    Philip E. Wolfson · 2014 · International Journal of Transpersonal Studies
  36. The Modulation of Glutamatergic Signaling as a Potential Therapeutic Strategy for Major Depression
    Patricio Molero, Enrique Aubá, María del Mar Unceta, Felipe Ortuño Sánchez Pedreño · 2022 · Springer eBooks
  37. The Link Between Dissociation and Religious/Spiritual Experiences
    Everton de Oliveira Maraldi · 2024 · Oxford University Press eBooks
  38. “Angry at the Wrong Thing:” Queering Ketamine Assisted Psychotherapy for Clients Experiencing Body Image and Eating Distress
    Jessalyn Maguire · 2024 · Studies in Clinical Social Work Transforming Practice Education and Research
  39. Clinical relevance of cognitive dysfunction in major depressive disorder
    Danielle S. Cha · 2015 · Cambridge University Press eBooks
  40. From psychache to neuroplasticity: A unified rescue-repair model of Ketamine’s anti-suicidal action
    Domany, Yoav, Solomon-Shashua, Aviv · 2026 · Neuroscience & Biobehavioral Reviews
  41. A computational model to characterize the time-course of response to rapid antidepressant therapies
    A. Nunes, Selena Singh · 2024 · PLoS ONE
  42. Case Report: A possible association between significant dissociations after esketamine treatment and histrionic personality disorder
    Veronika Savica, Liene Sīle, Māris Taube · 2025 · Frontiers in Psychiatry
  43. Clinical Predictors of Antidepressant Effects of Ketamine and Esketamine in Treatment-Resistant Unipolar and Bipolar Depression: A Systematic Review
    Omer A. Syed, Valentyne Sobolenko, Sean M. Nestor, Muhammad Ishrat Husain, Nir Lipsman, Fahad Alam, Peter Giacobbe · 2026 · CNS Drugs
  44. IARS Emery Brown Award 2026: Anesthetics and Serotonergic Psychedelics May Promote Therapeutic Neuroplasticity by Destabilizing Pathological Neuronal Circuitry
    Joseph Cichon · 2026 · Anesthesia & Analgesia
  45. Antidepressant and Abuse Potential of Ketamine
    Helge Hasselmann · 2016 · Elsevier eBooks
  46. Ketamine-Based Treatment of MDD: A Biologist’s Perspective
    Shupeng Li, Yingli Zhang, Qiang Zhou · 2017 · Journal of Depression And Therapy
  47. A Pain Physician and Anesthesiologist’s Perspective on Ketamine for Treatment-Resistant Depression
    Lauren E. Gatewood, Andrew W. Gorlin, Christopher H. Bailey, George Barsoum, Steven B. Porter · 2023 · SN Comprehensive Clinical Medicine
  48. Ketamin und Esketamin
    Cornelius Schüle, Gabi Koller, Uwe Herwig · 2024 · Nervenheilkunde
  49. Predictable Biomarkers for Rapid-Acting Antidepressant Response to Ketamine
    Yunfei Tan, Kenji Hashimoto · 2021 · Contemporary clinical neuroscience
  50. Ketamine and Other Glutamate Receptor Antagonists As Fast-Actin
    Mu‐Hong Chen, Tung‐Ping Su, Shih‐Jen Tsai · 2022 · Neuromethods
  51. Ketamine in Psychiatric Disorders
    Lena Vera Danyeli, Florian N. Götting, Zümrüt Duygu Şen, Meng Li, Martin Walter · 2022 · Springer eBooks
  52. Dissociative Disorders
    Damla E. Aksen, Steven Jay Lynn · 2025 · Cambridge University Press eBooks
  53. Dr Andrade Replies
    Chittaranjan Andrade · 2017 · The Journal of Clinical Psychiatry
  54. Is there a future for other glutamate receptor modulators in the pharmacotherapy of mood disorders?
    P. Šóš · 2016 · Evidence-Based Mental Health
  55. Ketamine Usage at Subanesthetic Doses and Psychoactive Effects
    Daniel Flack, Elias Dakwar · 2016 · Elsevier eBooks
  56. Article Open Access
    Holly Lawford‐Smith · 2015
  57. Ketamine: An important drug with a serious adverse effect - a review
    Roy Sebastian · 2018 · Journal of Psychology & Clinical Psychiatry
  58. Hur upplevda livsförändringar relaterar till enskilda, handledda psykedeliska sessioner
    Dennis Ekeberg · 2014 · DiVA (Södertörn University)
  59. Evaluation of the antidepressant potential of dextromethorphan
    Linda Nguyen · 2015
  60. Ketamine in Psychiatric Disorders
    Lena Vera Danyeli, Florian N. Götting, Zümrüt Duygu Şen, Meng Li, Martin Walter · 2021 · Springer eBooks
  61. (R)-Ketamine: A New Rapid-Acting Antidepressant
    Kai Zhang, Kenji Hashimoto · 2021 · Contemporary clinical neuroscience
  62. Analysis of the self-ignition of a turbulent gas jet in a stream of oxidizing agent
    V. N. Strokin · 1972 · OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information)
  63. Faculty Opinions recommendation of Attenuation of antidepressant effects of ketamine by opioid receptor antagonism.
    René Hen · 2018 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  64. Schnell wirksame Antidepressiva
    Zümrüt Duygu Şen, Lena Vera Danyeli, Martin Walter · 2022 · Springer eBooks
  65. Ketamine
    Joshua D. Di Vincenzo, Joshua Daniel Rosenblat, Roger S. McIntyre · 2023
  66. Comparação de eficácia da cetamina intramuscular e da combinação escitalopram e aripiprazol no tratamento agudo e manutenção da depressão resistente: ensaio clínico duplo cego, controlado com placebo, randomizado e de grupos paralelos
    Marco Aurélio Cigognini · 2023
  67. Case report: Maintaining altered states of consciousness over repeated ketamine infusions may be key to facilitate long-lasting antidepressant effects: some initial lessons from a personalized-dosing single-case study
    Steffen Reissmann, Matthias Hartmann, Andreas Kist, Matthias E. Liechti, Kurt Stocker · 2023 · Frontiers in Psychiatry
  68. Exploring inner depths
    Joost J. Breeksema · 2024
  69. Ketamine, Dissociation, and Depression: What Is “Special” About Ketamine? (Revisited)
    Mina Rizk, James W. Murrough · 2024 · The International Journal of Neuropsychopharmacology
  70. The parable of the TGA approval of esketamine (Spravato) in Australia: Part 2 - Submission for listing on the PBS
    William Lugg · 2025 · Australasian Psychiatry
  71. Altered States of Consciousness Induced by Subanesthetic Ketamine Influence Differential Effects on Negative Affect Circuitry in Response to Emotional Stimulation in Nonclinical Volunteers
    Laura M. Hack, Xue Zhang, Leanne Maree Williams · 2025 · Neuromethods
  72. Ritual to Relief: Ethical Frontiers in Repurposing Psychoactive Substances
    Emma O’Leary, Seetal Dodd, Stephen M. Stahl · 2025 · Cambridge University Press eBooks
  73. Ketamine as a prophylactic agent against post-traumatic stress disorder
    Julia Peavey · 2023 · Journal of High School Science
  74. Sympathetic activation but not dissociation linked to ketamine’s sustained antidepressant effect
    Veronika Andrashko, T. Novak, Miloslav Kopeček, Anna Šuláková, V. Knop, Jiri Horacek · 2026 · Therapeutic Advances in Psychopharmacology
  75. A Blueprint for Implementing Ketamine-Assisted Psychotherapy in Palliative Care: Design, Process, and Treatment Patterns of a Real-World Clinical Program
    Robert K. Horowitz, William E. Rosa, Ali John Zarrabi, Marc T. Swogger · 2026 · Journal of Palliative Medicine
  76. Effectiveness and factors associated with esketamine response during the 4-week induction period for treatment-resistant depression: post-hoc analysis of the real-world ESKALE study
    Ludovic Samalin, Maud Rothärmel, Lila Mékaoui, Anne Sauvaget, Clotilde Wicart, E. Gaudre-Wattinne, Vanessa Cohignac, Andrés Malatesta, Julien Dupin · 2026 · Journal of Psychiatric Research
  77. Esketamine hydrochloride in the management of moderate‐to‐severe depressive symptoms in patients undergoing multiple wound repair surgeries: A multi‐centre randomized, double‐blind, placebo‐controlled trial
    Xiaomeng Yu, Tianqi Shen, Ting Zhang, Rui Bao, Ziyi Guo, Zirui Feng, Li Tong, Xiaoying Zhang, Mingzi Ran, Guanyong Sun et al. · 2026 · Clinical and Translational Medicine
  78. Ketamine-induced changes in accumbal glutamate and their association with altered states of consciousness
    Ladina P Gubser, Anna Trippel, Niklaus Zoelch, Etna Engeli, Marcus Herdener · 2026 · Brain Research Bulletin
  79. Distinct Roles of Therapeutic Expectations and Dissociative Symptoms in Antidepressant Response During Ketamine Treatment in Routine Care
    Willys Cantenys, Zeynep Yoldas, Luc Masset, Alix Romier, Leonie Samion, Marion Imbault, Thai-Moc Tram Tran, Flávia M. Garcia, Samar Soltani, Martina Marradi et al. · 2026 · medRxiv
  80. The Unseen Burden: Mental Health in Patients with Haematological Malignancies — A Narrative Review
    Josipa Vlasac Glasnović · 2025 · Journal of Global Health Neurology and Psychiatry
  81. Dissociation and antidepressant response to subcutaneous esketamine: A clinical study
    Kaike Thiê da Costa Gonçalves, Vagner Deuel de Oliveira Tavares, Fernanda Palhano-Fontes, Patrícia Cavalcanti-Ribeiro, Victor Rocha Nóbrega de Almeida, David Cavalcante Barbosa, Tatiane Uetti Gomes Fernandes, Eduardo Igor Torquato Cardoso, Nicole Bezerra de Medeiros Lima, Aldielyson Jorge Cavalcante de Brito et al. · 2026 · Journal of Psychiatric Research
  82. A crucial cautionary note on frequently incorrect dose equivalence between ketamine and esketamine
    Rodolfo Furlan Damiano, Gustavo C. Medeiros, João Quevedo · 2026 · Molecular Psychiatry
  83. Ketamine‐Assisted Psychotherapy as an Approach to Psychedelic Healing
    Phil Wolfson · 2026 · Wiley eBooks
  84. Feasibility and tolerability of virtual reality during esketamine treatment: A pilot study
    Erin Curran, Kristina T. Kumpf, Mina Ansari, Nilufar Baghaei, Thomas C. Elliott, Samuel T. Wilkinson, Sina Nikayin · 2026 · Journal of Affective Disorders